Intracoastal Capital Bets On Spherix (SPEX); MediciNova (MNOV) Encouraging Trial Outcomes


Intracoastal Capital, LLC disclosed in a regulatory filing with the SEC ( SC 13G ) a 4.99% stake (2,447,291 shares) in Spherix Inc. (Nasdaq:SPEX).

SPEX stock closed at $0.1571, up $0.0069 (or +4.59%), and 1,099,361 shares of the company exchanged hands on Friday’s trading session

Spherix, an intellectual property development company, has 48.26M Shares Outstanding, Market Capitalization (intraday) of $7.58M and SPEX stock 52-week range is between $0.13 and $1.20 per share



MediciNova, Inc. (Nasdaq:MNOV) stock surged $0.06 (or +1.75%) to $3.48 on Friday, and 111,477 of its shares were traded during the day, increased activity versus its average volume (3m) of 37,083.

According to the company, interim data from an ongoing trial suggest that its MN-166 (ibudilast) has potential to improve respiratory function in people with amyotrophic lateral sclerosis

MediciNova, a biopharmaceutical company, has 25.96M Shares Outstanding, Market Capitalization (intraday) of $90.33M and MNOV stock one-year range is from $2.62 to $5.90 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at